Director Shaheen Wirk resigns from Tvardi Therapeutics board, no disagreement cited

Tvardi Therapeutics, Inc.

Shaheen Wirk resigned from the Board of Directors on July 8, 2025.
Resignation was not the result of any disagreement with the company.
Wirk had served as a board member since March 2024 and previously as a special advisor.
No replacement has been announced as of the filing date.

item 5.02

Tvardi Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-25-067785

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.